AQR Capital Management
BBNX

AQR Capital Management’s Beta Bionics BBNX Stock Holding History

AQR Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Buy
60,287
+9,882
+20% +$146K ﹤0.01% 3024
2025
Q4 		$1.54M Sell
50,405
-1,605
-3% -$42.9K ﹤0.01% 2308
2025
Q3 		$1.03M Sell
52,010
-3,423
-6% -$60.2K ﹤0.01% 2416
2025
Q2 		$807K Buy
+55,433
New +$785K ﹤0.01% 2326

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AQR Capital Management's BBNX Position: Q1 2026 in Review

AQR Capital Management increased its Beta Bionics (BBNX) stake by 20% in Q1 2026, buying an estimated $146K and bringing the position to 60,287 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #3024.

AQR Capital Management first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.54M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • AQR Capital Management held 60,287 shares of Beta Bionics worth $604K as of Q1 2026.
  • AQR Capital Management bought 9,882 Beta Bionics shares in Q1 2026, an estimated $146K.
  • Beta Bionics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3024 holding.
  • AQR Capital Management first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • AQR Capital Management's Beta Bionics position peaked at $1.54M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.